After writing dozens of GLP-1 articles over the past year, one issue that consistently comes up is the affordability of ...
Camurus announces positive topline results for CAM2056, semaglutide monthly depot: Lund, Sweden Tuesday, November 11, 2025, 16:00 Hrs [IST] Camurus, an international, science-led ...
CRIME gangs are making fake weight loss jabs that look like the real thing at an “industrial scale”, posing a significant ...
As you might expect, the competition to win a share of the expanding GLP-1 market is fierce right now, with giants Novo ...
A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and Wegovy, is a step toward making them ...
A White House deal with Eli Lilly & Co. and Novo Nordisk to lower the prices of their popular obesity medicines, Zepbound and Wegovy, is a step toward making them more affordable and accessible ...
Emcure Pharma becomes the first Indian company to hold exclusive rights to distribute and commercialise Poviztra, a ...
Novo Nordisk India and Emcure Pharma announced a strategic partnership on Monday to launch Poviztra (semaglutide injection ...
WASHINGTON -- Semaglutide (Wegovy) improved liver inflammation and fibrosis in patients with metabolic dysfunction-associated ...
Novo Nordisk A/S posted solid revenue and profit increases, with a resilient pipeline and strong dividend yield. Learn more ...
Everyday Health on MSN
Experimental Obesity Drug Could Soon Compete With Wegovy and Zepbound
Drugmaker Eli Lilly said it would soon start late-stage trials for eloralintide, a drug mimicking the pancreatic hormone ...
Below, doctors explain everything you need to know about the phenomenon. It’s important to be clear upfront that “Ozempic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback